(Q33422507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

1 reference

1 reference

Morten Orebo Holmström

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hans K. Hasselbalch

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Mads Emil Bjørn

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

23 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

125-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

The JAK2 V617F somatic mutation, mortality and cancer risk in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

Momelotinib treatment-emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

An immune dysregulation in MPN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1046867

10.3109/10428194.2015.1046867

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936872%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference